Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD. (50:19)
Dr. Doron Schneider and Dr. Jack Leahy discuss the 2012 ADA/EASD position statement on management of type 2 diabetes and its implications to clinical care.
A leading primary care physician and a world-renowned beta cell researcher discuss how understanding the pathophysiology of beta cells will influence a primary care doctor's choice of drug therapies for their patients. (28:39)
Doron Schneider, MD, a leading primary care physician and Jack Leahy, MD, a world-renowned beta cell researcher, discuss the new concepts, current research and therapies. (48:08)
A discussion of the impact of lifestyle modifications on the progression of diabetes between a leading primary care physician and a world-renowned beta cell researcher. (8:08)
A leading primary care physician and a world-renowned beta cell researcher discuss why it is important for primary care doctors to understand the role of beta cells in type 2 diabetes. (13:53)
